Monmouth Junction, NJ, United States of America

Kalyan Kathala

This inventor holds 28 USPTO granted patents and 16 published patent applications and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Tris Pharma, Inc., Tulex Pharmaceuticals Inc., Eton Pharmaceuticals, Inc.. Active years: 2015-2026.

USPTO Granted Patents = 28 (Patent Applications = 16)

% Patents Active = 96.4

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 412(Granted Patents)

Location History:

Monmouth Junction, NJ (US) (2015 - 2024)
Monroe, NJ (US) (2022 - 2024)

Company Filing History:

Tulex Pharmaceuticals Inc.

patents

3 out of 5

Eton Pharmaceuticals, Inc.

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Extended Release Tablets

Amphetamine Compositions

Oral Liquid Formulations

Desmopressin

Hydrocortisone

Methylphenidate

Epilepsy Treatment

Seizure Management

Non-Aqueous Solutions

Oral Compositions

Pharmaceutical Chemistry

Formulation Development

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734132 - Extended release amphetamine tablets (2026-09-15),

2. 12661360 - Ready to use non-aqueous solutions of lamotrigine (2026-06-23),

3. 12576125 - DESMOPRESSIN ORAL COMPOSITIONS (2026-03-17),

4. 12458592 - Extended release amphetamine tablets (2025-11-04),

5. 12419831 - Hydrocortisone oral liquid formulations (2025-09-23),

6. 12343372 - Desmopressin oral compositions (2025-07-01),

7. 12290503 - Compositions and methods for treating epilepsy, seizures and other conditions (2025-05-06),

8. 12214010 - Desmopressin oral compositions (2025-02-04),

9. 12133914 - Hydrocortisone oral liquid formulations (2024-11-05),

10. 12076441 - Extended release amphetamine tablets (2024-09-03),

11. 11911362 - Compositions and methods for treating epilepsy, seizures and other conditions (2024-02-27),

12. 11904046 - Hydrocortisone oral liquid formulations (2024-02-20),

13. 11826343 - Compositions and methods for treating epilepsy, seizures and other conditions (2023-11-28),

14. 11633389 - Methylphenidate extended release chewable tablet (2023-04-25),

15. 11633374 - Compositions and methods for treating epilepsy, seizures and other conditions (2023-04-25),

Title: Inventor Kalyan Kathala - Revolutionizing Technology

Introduction: Kalyan Kathala, a brilliant inventor hailing from Monmouth Junction, NJ, is a visionary in the realm of technology and innovation.

Latest Patents: Kalyan Kathala holds several groundbreaking patents in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Kathala has worked with prestigious research institutions and leading tech companies, consistently pushing the boundaries of what is possible in the world of technology.

Collaborations: Throughout his career, Kalyan Kathala has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and excellence in all his projects.

Conclusion: Inventor Kalyan Kathala's relentless pursuit of innovation and his passion for creating technology that shapes the future make him a true pioneer in the world of inventions.